KEMEXIVE Trademark
Serial Number: 79222202 • Registration: 5682562
KEMEXIVE is a trademark filed by
NOVARTIS AG
on September 27, 2017. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Trademark Details
Filing Date
September 27, 2017
Registration Date
February 26, 2019
Published for Opposition
February 20, 2018
Cancellation Date
May 22, 2024
Goods & Services
pharmaceutical preparations for the prevention and treatment of cancer and tumors
Filing History
DEATH OF INTERNATIONAL REGISTRATION
Dec 13, 2024 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 21, 2019 FICS
FINAL DISPOSITION PROCESSED
Jun 21, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 26, 2019 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 12, 2019 LIMN
REGISTERED-PRINCIPAL REGISTER
Feb 26, 2019 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Feb 8, 2019 LIMG
TTAB RELEASE CASE TO TRADEMARKS
Jan 17, 2019 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 17, 2019 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 17, 2019 OP.D
REFUSAL PROCESSED BY IB
Sep 7, 2018 RFNP
OPPOSITION INSTITUTED NO. 999999
Aug 29, 2018 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Aug 21, 2018 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Aug 21, 2018 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 22, 2018 ETOF
PUBLISHED FOR OPPOSITION
Feb 20, 2018 PUBO
NOTICE OF PUBLICATION
Jan 31, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2018 CNSA
ASSIGNED TO EXAMINER
Jan 3, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 12, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 4, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 30, 2017 SDRC
